GAMCO Investors’s Covetrus, Inc. Common Stock CVET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-440,541
Closed -$9.2M 943
2022
Q3
$9.2M Buy
440,541
+140,958
+47% +$2.93M 0.11% 220
2022
Q2
$6.22M Buy
299,583
+93,097
+45% +$1.66M 0.07% 287
2022
Q1
$3.47M Buy
206,486
+4,899
+2% +$85.6K 0.03% 404
2021
Q4
$4.03M Buy
201,587
+1,389
+0.7% +$26.1K 0.03% 387
2021
Q3
$3.63M Buy
200,198
+39,206
+24% +$899K 0.03% 407
2021
Q2
$4.35M Buy
160,992
+151
+0.1% +$4.22K 0.04% 384
2021
Q1
$4.82M Sell
160,841
-7,904
-5% -$270K 0.04% 353
2020
Q4
$4.85M Buy
168,745
+830
+0.5% +$22.4K 0.05% 340
2020
Q3
$4.1M Sell
167,915
-27,260
-14% -$588K 0.05% 347
2020
Q2
$3.49M Sell
195,175
-8,192
-4% -$108K 0.04% 365
2020
Q1
$1.66M Sell
203,367
-14,173
-7% -$162K 0.02% 468
2019
Q4
$2.87M Buy
217,540
+20,946
+11% +$254K 0.02% 442
2019
Q3
$2.34M Sell
196,594
-9,607
-5% -$178K 0.02% 463
2019
Q2
$5.04M Buy
206,201
+25,202
+14% +$726K 0.04% 360
2019
Q1
$5.76M Buy
+180,999
New +$6.42M 0.04% 335

Other funds holding CVET

GAMCO Investors's CVET Position: Q4 2022 in Review

GAMCO Investors sold out of Covetrus, Inc. Common Stock (CVET) in Q4 2022, closing a stake of 440,541 shares — an estimated $9.2M sold.

GAMCO Investors first reported a position in CVET in Q1 2019 and held it in 15 quarters. The position peaked at $9.2M in Q3 2022. 5 funds tracked by Wall St. Rank hold CVET as of Q4 2022.

  • GAMCO Investors reported no remaining Covetrus, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • GAMCO Investors sold 440,541 Covetrus, Inc. Common Stock shares in Q4 2022, an estimated $9.2M.
  • GAMCO Investors first reported a position in Covetrus, Inc. Common Stock in Q1 2019 and held it in 15 quarters.
  • GAMCO Investors's Covetrus, Inc. Common Stock position peaked at $9.2M in Q3 2022.
  • 5 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q4 2022.

Based on GAMCO Investors's 13F filing for Q4 2022, filed 13 Feb 2023.